United Therapeutics (UTHR) Misses Q2 EPS by 94c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $493.10 -0.31%
EPS Growth %: -10.1%
Financial Fact:
Net income per basic common share (in dollars per share): 3.75
Today's EPS Names:
ALZN, ASPU, OCCI, More
EPS Growth %: -10.1%
Financial Fact:
Net income per basic common share (in dollars per share): 3.75
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q2 EPS of $6.41, $0.94 worse than the analyst estimate of $7.35. Revenue for the quarter came in at $798.6 million versus the consensus estimate of $804.98 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GameStop CEO Cohen buys 1.15M shares
- Morgan Stanley Upgrades Coal India Ltd (COAL:IN) to Overweight
- Berenberg Upgrades Cranswick Plc. (CWK:LN) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
